CENTR Brands Corp.

OTC: CNTRF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

17D

FH 14DQ —GM 20SS 31

v0.1 · 45/100 weight · provisional

↑ disclosure history, Piotroski F · ↓ 3-yr revenue growth, balance-sheet leverage

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$315.3k

Employees

Market cap

$498.5k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02025

Net income-$315.3k-$315.3k2025

Operating income-$400.0k-$400.0k2025

Total assets$12.9k$12.9k2025

Liabilities$1.2M$1.2M2025

Equity-$1.2M-$1.2M2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

$463.2k

FY20

$762.5k

FY21

$1.9M

FY22

$859.2k

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

CENTR Brands Corp. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

NovelStem International Corp.37D Doseology Sciences Inc.40D BiomX Inc.——Therapeutic Solutions International, Inc.——

Key facts

CEORobert W. Campbell Becher

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: CNTRF

Employees18

IPO date2020-04-27

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.